ONCOLYTICS BIOTECH INC - Common Stock, no par value (ONCY)

Historical Holders from Q2 2018 to Q1 2025

Symbol
ONCY on Nasdaq
CUSIP
682310875
Type / Class
Equity / Common Stock, no par value
Shares outstanding
85.3M
All holders as of December 31, 2024
Q4 2024
Shares, excl. options
1.31M
Holdings value
$1.21M
% of all portfolios
0%
Grand Portfolio weight change
+0%
Number of holders
46
Number of buys
20
Number of sells
-12
Average Value change %
+0%
Average buys %
+0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of ONCOLYTICS BIOTECH INC - Common Stock, no par value (ONCY)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Anson Funds Management LP 9.6% $4.5M 8.19M Anson Funds Management LP Dec 31, 2024

Institutional Holders of ONCOLYTICS BIOTECH INC - Common Stock, no par value (ONCY)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q1 90.8K $49.7K +$7.18K $0.55 7
2024 Q4 1.31M $1.21M +$65K $0.91 46
2024 Q3 1M $872K -$113K $0.87 40
2024 Q2 1.31M $1.3M -$123K $0.99 41
2024 Q1 803K $851K -$5.27M $1.06 13
2023 Q4 5.14M $6.93M -$1.68M $1.35 40
2023 Q3 6.21M $13.6M +$11.9M $2.18 31
2023 Q2 787K $2.05M -$91.6K $2.60 26
2023 Q1 1.1M $1.32M +$297K $1.20 29
2022 Q4 881K $1.45M +$324K $1.63 30
2022 Q3 699K $865K -$195K $1.23 26
2022 Q2 899K $901K +$196K $1.00 31
2022 Q1 695K $1.1M -$751K $1.58 28
2021 Q4 1.18M $1.64M +$134K $1.40 31
2021 Q3 900K $1.88M -$202K $2.09 31
2021 Q2 902K $2.46M -$515K $2.77 36
2021 Q1 1.05M $3.83M +$250K $3.81 36
2020 Q4 1.04M $2.47M +$737K $2.38 27
2020 Q3 758K $1.3M -$180K $1.70 24
2020 Q2 800K $1.51M +$529K $1.88 27
2020 Q1 414K $568K +$9.7K $1.36 12
2019 Q4 364K $1.73M +$216K $4.76 21
2019 Q3 377K $215K -$568K $0.58 10
2019 Q2 564K $959K +$646K $1.68 11
2019 Q1 186K $344K +$64.5K $1.87 16
2018 Q4 148K $267K -$180K $1.77 13
2018 Q3 162K $611K -$1.61M $3.82 14
2018 Q2 578K $3.18M +$3.18M $5.43 16